Ferric pyrophosphate citrate Route Not Applicable and Ranibizumab
Determining the interaction of Ferric pyrophosphate citrate Route Not Applicable and Ranibizumab and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: ferric pyrophosphate
Brand name: Triferic
Synonyms: Ferric pyrophosphate, Ferric Pyrophosphate Citrate
Generic Name: ranibizumab ophthalmic
Brand name: Lucentis
Synonyms: Ranibizumab (ophthalmic)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Ferric pyrophosphate citrate Route Not Applicable-Ranibizumab Intraocular
- Ferric pyrophosphate citrate Route Not Applicable-Ranibizumab ophthalmic
- Ferric pyrophosphate citrate Route Not Applicable-Ranitidine
- Ferric pyrophosphate citrate Route Not Applicable-Ranitidine Capsule
- Ferric pyrophosphate citrate Route Not Applicable-Ranitidine Hydrochloride
- Ferric pyrophosphate citrate Route Not Applicable-Ranitidine Injection
- Ranibizumab-Ferric-x 150
- Ranibizumab-Ferriprox
- Ranibizumab-Ferriprox (Deferiprone Oral Solution)
- Ranibizumab-Ferriprox (Deferiprone Tablets)
- Ranibizumab-Ferriprox Oral Solution
- Ranibizumab-Ferrlecit